Therapeutic benefit of larotrectinib over the historical standard of care in patients with locally advanced or metastatic infantile fibrosarcoma (EPI VITRAKVI study)

Orbach, D.; Carton, M.; Khadir, S. K.; Feuilly, M.; Kurtinecz, M.; Phil, D.; Vokuhl, C.; Koscielniak, E.; Pierron, G.; Lemelle, L.; Sparber-Sauer, M.

dc.contributor.author	Koscielniak, Ewa
dc.contributor.author	Sparber-Sauer, Monika
dc.date.accessioned	2025-02-04T07:04:57Z
dc.date.available	2025-02-04T07:04:57Z
dc.date.issued	2024
dc.identifier.issn	2059-7029
dc.identifier.uri	http://hdl.handle.net/10900/161570
dc.language.iso	en	de_DE
dc.publisher	Amsterdam : Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.esmoop.2024.103006	de_DE
dc.subject.ddc	610	de_DE
dc.title	Therapeutic benefit of larotrectinib over the historical standard of care in patients with locally advanced or metastatic infantile fibrosarcoma (EPI VITRAKVI study)	de_DE
dc.type	Article	de_DE
utue.quellen.id	20241001000000_01738
utue.personen.roh	Orbach, D.
utue.personen.roh	Carton, M.
utue.personen.roh	Khadir, S. K.
utue.personen.roh	Feuilly, M.
utue.personen.roh	Kurtinecz, M.
utue.personen.roh	Phil, D.
utue.personen.roh	Vokuhl, C.
utue.personen.roh	Koscielniak, E.
utue.personen.roh	Pierron, G.
utue.personen.roh	Lemelle, L.
utue.personen.roh	Sparber-Sauer, M.
dcterms.isPartOf.ZSTitelID	Esmo Open	de_DE
dcterms.isPartOf.ZS-Issue	Article 103006	de_DE
dcterms.isPartOf.ZS-Volume	9 (5)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE